Planned PMA Pathway Modeled On Existing Accelerated Programs

CDRH’s plans for a specialized pathway for high-risk PMA devices that address unmet medical needs will be modeled on the drug center’s recently established breakthrough therapy pathway, and also the device center’s Innovation Pathway.

More from Regulation

More from Policy & Regulation